ResearcherLoma Linda UniversityActive in the last 2 years

Huynh Le Cao

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5083527262. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jeffrey Xiao · 1 shared paper, 2025 · strength 0.19
- Paper Targeting DNA helicase CMG complex and NFκB2-driven drug-resistant transcriptional axis to effectively treat KRAS G12D-… DOI 10.1186/s40164-025-00669-w ↗
Yi Xu · 1 shared paper, 2025 · strength 0.19
- Paper Targeting DNA helicase CMG complex and NFκB2-driven drug-resistant transcriptional axis to effectively treat KRAS G12D-… DOI 10.1186/s40164-025-00669-w ↗
Diana L. Hanna · 1 shared paper, 2025 · strength 0.19
- Paper Targeting DNA helicase CMG complex and NFκB2-driven drug-resistant transcriptional axis to effectively treat KRAS G12D-… DOI 10.1186/s40164-025-00669-w ↗
Li‐Xi Yang · 1 shared paper, 2013 · strength 0.06
- Paper Current status in chemotherapy for advanced pancreatic adenocarcinoma. PMID 23645722 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.